RUTH CHEVEZ: Open Payments
NPI 1134599285 · LINCOLN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$954 in 34 payments from 15 companies in 2025. Trend: 2023 $280 · 2024 $148 · 2025 $954
Food & beverage: $954
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $316 |
| Indivior Inc. | 3 | $91 |
| Lilly USA, LLC | 3 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Phathom Pharmaceuticals, Inc. | 1 | $50 |
| Lundbeck LLC | 2 | $49 |
| PFIZER INC. | 2 | $36 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
Products named: VRAYLAR, REXULTI, SUBLOCADE, RELISTOR, KISUNLA, CAPLYTA, VOQUEZNA, UBRELVY.
Industry payments across RI — which companies pay providers there.
